Annexin A2 is a calcium-dependent, phospholipid-binding protein found on many cell types. It consists of a short hydrophobic tail (Ser 2 -Asn 32 ), which dictates its function, and a core domain (Phe 33 -Asp 339 ), which is involved in phospholipid binding. Annexin A2 has been implicated in a number of biochemical processes, including cell proliferation, foetal immune tolerance, ion-channel activation, cell-cell interactions and the bridging of membranes. Annexin A2 is reported to be a powerful activator of plasminogen and, therefore, is implicated in many normal and pathological processes such as haemostasis and metastasis. Myeloid cell lines are used, extensively, to study many aspects of cellular proliferation, differentiation and function. In the present study, we have used flow cytometry and real-time PCR to investigate the role of annexin A2 expression in the proliferation and differentiation of a number of myeloid cell lines. The results demonstrated that annexin A2 expression was affected when the cells were induced to differentiate by stimulation with all-trans-retinoic acid. Annexin A2 may, therefore, be an important player in cellular differentiation and its disorders.
Introduction
Annexins are a family of homologous calcium-dependent proteins, named because of their ability to annex anionic phospholipid membranes [1] . Calcium acts to shift the annexins from a soluble to a membrane-associated state [2] . Most annexins are composed of a strongly conserved planar array of four homologous domains (comprised of 70-aminoacid long repeats), each containing five α-helices [2] . These domains are approximately co-planar and arranged symmetrically into two modules [3] . The repeat sequences contain the area known as the 'endonexin-fold' with its identifying GXGTDE sequence [4] . Viewed from the side, the annexin molecule has a convex surface that faces the plasma membrane and a concave surface facing away [4, 5] . The convex surface includes the interhelical loops, whereas the concave surface includes the capping helices and the N-terminus; both have an extended conformation. In this way, the N-terminus, with its variable sequence, can be accommodated without interfering with calcium-dependent membrane binding [6] .
Thirteen members of this multigene family have been characterized with at least ten being present in mammalian tissue [4] . While there has been a large amount of information accumulated on the molecular properties of annexins, the understanding of their individual physiological functions remains a challenge. Annexins have been linked to the regulation of ion conductance through the formation of ion channels, the modulation of fibrinolysis, the aggregation of vesi- cles and the cytoskeleton together with many other diverse biological roles [1] [2] [3] [7] [8] [9] . The near-ubiquity of the presence of annexins amongst eukaryotic organisms suggests both fundamental biological roles and more complex secondary mechanisms [4] .
Annexin A2
Annexin A2 is a calcium-dependent, phospholipid-binding protein found on the surface of many cell types [1, 10] . It consists of a short hydrophilic terminal tail domain (Ser 2 -Asn 32 ), which dictates its individual function and a core domain (Phe 33 -Asp 339 ), comprising approx. 90% of its molecular mass, that is involved in phospholipid binding [8, 11] . Annexin A2 exists both as a monomer and a bivalent heterotetramer [1] . The ANX2 monomer is mainly present in the cytosol, whereas the formation of the heterotetramer (two copies of annexin A2 bound to a dimer of p11) results in the association of the complex with the plasma membrane [2] .
The annexin A2 export mechanism from the cell is unknown as it lacks a classical signal peptide; however, on endothelial cells, it is translocated to the cell surface within 16 h of biosynthesis [8] . The possibility that the annexin A2 monomer may have a different physiological role to play than the annexin II tetramer has been raised by several researchers. These two forms are found in different cellular locations and kinetic studies have shown differing abilities to bind calcium. Annexin A2 has been implicated in cell proliferation, angiogenesis, foetal immune tolerance, ion-channel activation, cell-to-cell interactions and the bridging of membranes [1, [12] [13] [14] [15] .
Annexin A2 in haemostasis and fibrinolysis
One of the roles of annexin A2 in pathophysiological processes may be in its ability to affect haemostasis. Annexin A2 is a cell-surface profibrinolytic co-receptor for tPA (tissue plasminogen activator) and PLG (plasminogen) with increased levels supposed to play a role in hyperfibrinolytic events [16, 17] . Many reports have demonstrated that cellsurface annexin A2 monomer can independently bind both tPA and PLG [5, 17] . Both molecules are positioned in close proximity to each other on the surface of annexin II, providing an ideal environment for the activation of PLG by tPA. Cell receptors that localize tPA and PLG on the cell surface serve a profibrinolytic function. PLG and tPA binding to annexin A2 enhances plasmin activity by augmenting PLG activation, increasing the enzymic activity of plasmin, and protecting plasmin from the negative actions of its inhibitors [18] .
It has been shown that when soluble annexin A2 was added to a mixture of PLG and tPA, there was a 60-fold increase in the rate of plasmin generation [16] . However, some researchers feel that the annexin A2 tetramer may play a greater kinetic role as a stimulator of fibrinolysis than the monomer [8, 19] . These paradoxical views suggest that the physiological role of annexin A2 monomer and tetramer in fibrinolysis is probably complex and that full understanding must await analysis of in vivo model systems in both humans and animals [8] .
Annexin A2 has been linked to a number of haemostatic processes. Reports have shown that annexin A2 binds homocysteine at the same tail domain as tPA. In this way, plasma homocysteine can prevent tPA binding, thus reducing the fibrinolytic potential of a cell, and may increase the risk of cardiovascular disease [14, 20, 21] . Lipoprotein(a) has also been shown to reduce the fibrinolytic capabilities of the cell by competing with PLG for its binding site within the core domain of annexin A2 [22] .
Annexin A2 in myeloid differentiation and malignancy
Annexin A2 has been shown to be up-regulated in many neoplastic diseases. The presence of annexin A2 on neoplastic cells may lead to activation of PLG, resulting in increased metastatic capacity of cancerous cells or to bleeding disorders in the patients. One of the most studied of these diseases is APL (acute promyelocytic leukaemia). Here, annexin A2 has been implicated in the hyperfibrinolytic events, which often accompany APL [10, 23] . Increased expression of annexin A2 on the surface of APL cells has been associated with the bleeding complications observed in the disease. There is a suggestion that the presence of annexin A2 on immature or blast cells leads to a fibrinolytic propensity.
We have investigated the expression of annexin A2 in a range of leukaemic cell lines that represent the major types of myeloid leukaemia. The expression of annexin A2 on the leukaemic cell lines was evaluated by flow cytometry and by real-time PCR. Annexin A2 was expressed in all of the leukaemic cell lines studied. Furthermore, when the cells were induced to differentiate into more mature myeloid cells, annexin A2 expression was down-regulated.
Annexin A2 may play an important role in cell proliferation and differentiation and may profoundly affect the development and progression of neoplastic disease.
